MDNews - Mid Penn

Innovations 2022

Issue link: https://viewer.e-digitaledition.com/i/1481285

Contents of this Issue

Navigation

Page 12 of 15

such as medication, invasive surgery or watchful waiting. THE SETBACK IN THE PROCESS Pediatric medical devices must undergo the same FDA approval process as adult devices, which involves: 1—Creating a prototype 2 —Te s t i n g t he pr ot ot y p e f i r s t i n benchwork, then in human tria ls after FDA consultation 3—Product approval and going to market But un like adu lt dev ices, pediatric technology lags significantly behind. According to Juan Espinoza, MD, FAAP, Pr i ncipa l Investigator at The Saba n Research Institute and Director of The West Coast Consortium for Technology & Innovation in Pediatrics at Children's Hospital Los Angeles, the reason for this lag can be split into four distinguishable categories: clinical, technical, regulatory and financial. CLINICAL AND TECHNICAL CONSIDERATIONS FOR PEDIATRIC DEVICE APPROVAL Pediatric patients a re physiologica lly a nd neu rodevelopment a l ly d i f ferent from adults. When developing devices for children, researchers must be cogni- zant of the long-term growth of the child, and therefore, the long-term growth of the device. " Me d ic a l dev ic e developer s mu s t consider the progressive growth of pedi- atric patients, which may impact the size, function and design of a device," writes Dr. Espinoza in "Pediatric Medical Device Development and Regulation: Current S t at e, Ba r r ier s , a nd O ppor t u n it ies " published in Pediatrics. "Physiologically, mu lt iple orga n s ystem s, such a s t he cardiovascular, respirator y, and rena l systems, change from childhood to adult- hood, with significant implications for medical devices." This means researchers aren't developing one device for approval; they're developing at least six — one each for neonates, infants, toddlers, school-aged children, teenagers and young adults. However, some materials or designs won't work for miniature-sized models, making device engineering difficult and requiring developers to find other tech- nology or draft new designs that work on a smaller scale. Even then, regulatory issues can present additional challenges. Human tria ls require researchers to test on children. Because children are a protected class, this presents a unique set of challenges and delays, particularly in regard to institutiona l review board (IRB) approval. Even when researchers receive IRB approval, they must find chil- dren whose parents will agree to testing, making recruitment difficult. FINANCIAL BARRIERS Financia l consideration is the biggest ba r r ier t o ped i at r ic med ica l dev ice development a nd approv a l b e c a u s e pediatrics occupies a fraction of t he healthcare market. "Most pediatric medica l devices a re for a much sma ller ma rket tha n adult devices," Dr. Fischer says. "This ma kes it difficult to find funding to get through t he va r ious development pha ses of a medica l device." Dr. Espi noza a g rees t hat f i na ncia l incentives are low for companies invest- ing in pediatric medica l devices. "If a company ma kes a vascular graft, for example, they have two choices: they can either make an adult graft and have 3 million customers a year, or they can make a pediatric graft and have 600 customers," Dr. Espinoza says. "There's no magica l price they can put on a per unit cost to recoup that difference. Fina nce is the single largest gap we need to close." HOPE IS NOT LOST Pediatric medica l device development may lag significantly behind that of adult devices, but improvements are under- way. The FDA established the System of Hospita ls for Innovation in Pediatrics – Medica l Devices (SHIP-MD). SHIP- MD's framework is to connect qualified children's hospitals that are evaluating the safety of pediatric medical devices with the intent to accelerate development, reduce risk and stimulate investment. With SHIP-MD, researchers hope to close developmental and approval gaps in pediatric medical devices. When this happens, providers will be able to give more children — like Andrew — a chance to grow up healthy. n The 'Make Your Medical Device Pitch for Kids!' Competition Shines a Spotlight on Lifesaving Technology AT TEMP TING TO REMOV E the financial hurdle for pediatric medical device developers, the National Capital Consortium for Pediatric Device Innovation has established "Make Your Medical Device Pitch for Kids!," an annual competition that provides developers the opportunity to fund their research with $150,000 in FDA grants. Starlight Cardiovascular, one of last year's five winners, presented Project Lifeline, a ductus arteriosus stent system for pediatric patients. "In babies born with certain critical congenital heart defects, the ductus arteriosus may be the only thing keeping the newborn alive — supplying critical blood to either the lungs or the body," says Beverly Tang, PhD, CEO at Starlight Cardiovascular. "The Lifeline Ductus Arteriosus Stent System is designed specifically for this unique anatomy, providing a flexible, self-expanding stent delivered through a microcatheter delivery system." Learn more about the program at innovate4kids.org. M D N E W S . C O M /// M D N E W S M I D - P E N N ■ 2 0 2 2 1 3

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Mid Penn - Innovations 2022